## 3 Results
### Static Postural Control
\begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline  & \multicolumn{3}{c}{**Eyes Open**} & \multicolumn{3}{c}{**Eyes Closed**} & \multirow{2}{*}{**ANOVA**} & \multirow{2}{*}{\(F\)} & \multicolumn{2}{c}{**Effect Size**} \\ \cline{1-2} \cline{6-8}
**Measures (s)** & & & & & & **(95\% CI)** & \\ \hline \multirow{3}{*}{\begin{tabular}{c} TTB ML \\ Mean of minima \\ \end{tabular} } & \multirow{3}{*}{\(3.4\pm 0.76\)} & \multirow{3}{*}{\(3\pm 0.34\)} & \multirow{3}{*}{\(1.78\pm 0.46\)} & \multirow{3}{*}{\(1.74\pm 0.43\)} & Fatigue Effect & \multirow{3}{*}{\(7.826741\)} & \multirow{3}{*}{\(0.6\) (\(0.055 to 0.360\))} \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & & \(201.0951\) & & \(1.634\) \\ \hline \multirow{3}{*}{\begin{tabular}{c} TTB AP \\ Mean of minima \\ \end{tabular} } & \multirow{3}{*}{\(9.99\pm 1.43\)} & \multirow{3}{*}{\(4.53\pm 0.91\)} & \multirow{3}{*}{\(4.92\pm 1.1\)} & \multirow{3}{*}{\(4.79\pm 0.94\)} & Fatigue Effect & \multirow{3}{*}{\(81.72411\)} & \multirow{3}{*}{\(0.52\) (\(1.860\) to 2.953)} \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \hline \multirow{3}{*}{\begin{tabular}{c} TTB AP \\ SD on minima \\ \end{tabular} } & \multirow{3}{*}{\(2.9\pm 1.17\)} & \multirow{3}{*}{\(2.45\pm 1.16\)} & \multirow{3}{*}{\(1.59\pm 0.83\)} & \multirow{3}{*}{\(1.56\pm 0.63\)} & Fatigue Effect & \multirow{3}{*}{\(63.98371\)} & \multirow{3}{*}{\(0.57\) (\(-0.040\) to 0.515)} \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \hline \multirow{3}{*}{\
\begin{tabular}{c} TTB AP \\ SD on minima \\ \end{tabular} } & \multirow{3}{*}{\(6.11\pm 1.23\)} & \multirow{3}{*}{\(2.69\pm 0.53\)} & \multirow{3}{*}{\(3.33\pm 0.94\)} & \multirow{3}{*}{\(3.19\pm 0.83\)} & Fatigue Effect & \multirow{3}{*}{\(106.8657\)} & \multirow{3}{*}{\(0.33\) (\(0.717\) to 1.629)} \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \hline \multirow{3}{*}{
\begin{tabular}{c} TTB AP \\ SD on minima \\ \end{tabular} } & \multirow{3}{*}{\(6.11\pm 1.23\)} & \multirow{3}{*}{\(2.69\pm 0.53\)} & \multirow{3}{*}{\(3.33\pm 0.94\)} & \multirow{3}{*}{\(3.19\pm 0.83\)} & Fatigue Effect & \multirow{3}{*}{\(106.8657\)} & \multirow{3}{*}{\(0.33\) (\(0.717\) to 1.629)} \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & \(201.0951\) & & \(1.634\) \\ \cline{3-3} \cline{5-6}  & & & & & \(201.0951\) & & \(1.634\) \\ \hline \hline \end{tabular}
\end{table} 
Table 3: Mean (\(\pm\)SD) for the time-to-boundary (TTB) measures of postural control with eyes open and closed before and after the fatigue protocol.